Lyla Stanland
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$2.7MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 14, 2026 | NIH | SBIR Phase II Overcoming Adaptive KRAS Inhibitor Resistance with Ligand-Directed KRAS G12V-panTEAD Chimeras | $312K | ENFUEGO THERAPEUTICS, INC. |
| Sep 3, 2025 | NIH | SBIR Phase II Ligand-Directed KRAS G12V Mutant-Specific Therapeutics | $919K | ENFUEGO THERAPEUTICS, INC. |
| Jul 9, 2024 | NIH | SBIR Phase II Ligand-Directed KRAS G12V Mutant-Specific Therapeutics | $919K | ENFUEGO THERAPEUTICS, INC. |
| Jul 5, 2023 | NIH | SBIR Phase II Ligand-Directed KRAS G12V Mutant-Specific Therapeutics | $276K | ENFUEGO THERAPEUTICS, INC. |
| Jul 5, 2023 | NIH | SBIR Phase I Ligand-Directed KRAS G12V Mutant-Specific Therapeutics | $276K | ENFUEGO THERAPEUTICS, INC. |
Peer ranks
Federal funding#706
Awards as PI#417
Patents#273
Companies
- ENFUEGO THERAPEUTICS, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.